RERF-LC-KJHomo sapiens (Human)Cancer cell line

Also known as: Radiation Effects Research Foundation-Lung Cancer-KJ, KJ, RERFLCKJ, REAF-LC-KJ2

🤖 AI SummaryBased on 10 publications

Quick Overview

Human lung cancer cell line with EGFR mutations and metastatic potential.

Detailed Summary

RERF-LC-KJ is a human lung cancer cell line derived from a squamous cell carcinoma. It is known for its EGFR mutations and has been used in studies related to lung cancer metastasis and drug sensitivity. This cell line has been utilized in research to understand the genetic and molecular mechanisms underlying cancer progression and treatment responses. It is also part of various cancer cell line panels, contributing to the study of tumor biology and therapeutic strategies.

Research Applications

EGFR mutation analysisMetastasis studiesDrug sensitivity profilingGenomic and transcriptomic analysis

Key Characteristics

EGFR mutationsMetastatic potentialUsed in cancer research panels
Generated on 6/17/2025

Basic Information

Database IDCVCL_1654
SpeciesHomo sapiens (Human)

Donor Information

Age78
Age CategoryAdult
SexMale

Disease Information

DiseaseLung adenocarcinoma
LineageLung
SubtypeLung Adenocarcinoma
OncoTree CodeLUAD

DepMap Information

Source TypeHSRRB
Source IDACH-000482_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Glu224Valfs (c.670_671insTGTCT)Unspecified-from parent cell line RERF-LC-KJ

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X,Y
CSF1PO
12
D13S317
10
D16S539
11
D18S51
12
D21S11
29
D3S1358
17
D5S818
10
D7S820
10,11
D8S1179
12,14
FGA
21,26
Penta D
10
Penta E
11,17
TH01
7,9
TPOX
11
vWA
17
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Genetic diversity among the present Japanese population: evidence from genotyping of human cell lines established in Japan.

Kasai F., Fukushima M., Miyagi Y., Nakamura Y.

Hum. Cell 37:944-950(2024).

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

A resource for cell line authentication, annotation and quality control.

Neve R.M.

Nature 520:307-311(2015).

A comprehensive transcriptional portrait of human cancer cell lines.

Settleman J., Seshagiri S., Zhang Z.-M.

Nat. Biotechnol. 33:306-312(2015).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

Scid mice model for the in-vivo study of human oncotherapy -- studies on the growth and metastasis of human lung-cancer.

Teraoka S., Kyoizumi S., Seyama T., Yamakido M., Akiyama M.

Int. J. Oncol. 5:501-508(1994).

A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.

Haber D.A.

Cancer Res. 70:2158-2164(2010).

Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp.

Fukuyama S., Yokote A., Kobayashi K., Kanazawa M., Hagiwara K.

Cancer Res. 65:7276-7282(2005).

Correlation between DNA alterations and p53 and p16 protein expression in cancer cell lines.

Murai Y., Hayashi S., Takahashi H., Tsuneyama K., Takano Y.

Pathol. Res. Pract. 201:109-115(2005).

Frequent silencing of DBC1 is by genetic or epigenetic mechanisms in non-small cell lung cancers.

Hirohashi S., Inazawa J., Imoto I.

Hum. Mol. Genet. 14:997-1007(2005).

A novel SCID mouse model for studying spontaneous metastasis of human lung cancer to human tissue.

Teraoka S., Kyoizumi S., Seyama T., Yamakido M., Akiyama M.

Jpn. J. Cancer Res. 86:419-423(1995).